What do frozen samurai warriors and magic goggles have to do with treating cancer?


Join Precision BioSciences Chief Science Officer Derek Jantz on a journey into the future of cancer therapies and learn how ARCUS —Precision's genome editing technology— is used to make allogeneic, donor-derived CAR T cell therapies with the potential to change the way the world battles cancer.